MYSTERIOUS: Do wall street analysts like boston scientific stock - What They Never Told You

With a market cap of $149 billion, Boston Scientific Corporation (BSX) develops, manufactures, and markets innovative medical devices used in various interventional medical specialties worldwide. It operates through two main segments: MedSurg and Cardiovascular, offering advanced solutions for diagnosing and treating complex conditions across gastrointestinal, urological, neurological, and cardiovascular care.

Shares of the Marlborough, Massachusetts-based company have outperformed the broader market over the past 52 weeks. BSX stock has increased 19.9% over this time frame, while the broader S&P 500 Index ($SPX) has gained over 18%. However, shares of the company have risen 12.7% on a YTD basis, lagging behind SPX's 16.7% YTD return.